Krebs Biochemicals & Industries Limited

NSE KREBSBIO.NS

Krebs Biochemicals & Industries Limited Price to Sales Ratio (P/S) on February 07, 2025: 4.18

Krebs Biochemicals & Industries Limited Price to Sales Ratio (P/S) is 4.18 on February 07, 2025, a 34.09% change year over year. Price to sales ratio compares the stock price to the sales per share; higher suggests positive sentiment for future revenue growth.

Krebs Biochemicals & Industries Limited 52-week high Price to Sales Ratio (P/S) is 5.32 on November 27, 2024, which is 27.25% above the current Price to Sales Ratio (P/S).
Krebs Biochemicals & Industries Limited 52-week low Price to Sales Ratio (P/S) is 2.51 on March 28, 2024, which is -39.86% below the current Price to Sales Ratio (P/S).
Krebs Biochemicals & Industries Limited average Price to Sales Ratio (P/S) for the last 52 weeks is 3.49.

Key data

Date	Price to Sales Ratio (P/S)	Price to Book Ratio (P/B)	Dividend Yield	Free Cash Flow Yield

NSE: KREBSBIO.NS

Krebs Biochemicals & Industries Limited

CEO	Mr. Jitendra Rameshchandra Shah
IPO Date	Oct. 27, 2016
Location	India
Headquarters	Maas Heights
Employees	191
Sector	Healthcare
Industries Pharmaceuticals Biotechnology Cosmetics Drugstores & Retail Pharmacies Eyewear Non-Alcoholic Beverages Personal Care Plastics

Description

Krebs Biochemicals & Industries Limited manufactures and sells active pharmaceutical ingredients in India. The company develops biotech processes for application in medicine, agriculture, and industry fields. Its products, such as androstenedione, lovastatin, and simvastatin for anti-cholesterol and steroid intermediate applications. The company is also developing various products, including amlodipine, cetirizine, orlistat, serratiopepetidase, telmisartan, and phenylephrine for anti-hypertension, anti-histamine, anti-obesity, anti-inflammatory, and cold and cough applications. In addition, it offers contract manufacturing services for large pharmaceutical and multinational companies. Krebs Biochemicals & Industries Limited was incorporated in 1991 and is headquartered in Hyderabad, India.

Key trends

Past 5 years